Biomarkers-based personalized follow-up in chronic heart failure improves patient’s outcomes and reduces care associate cost

Table 1 Categories of costs included in the analysis, per unit

	Cost (€)
Hospitalization cost	3981.89
NYHA 1	2900.76
NYHA 2	3654.64
NYHA 3	4426.22
NYHA 4	6662.33
Primary care visits	78.45
Emergency Department visits	392.03
Heart Failure Unit visits	97.83
Medication cost	1.32
ACE I	0.09
ARA II	0.54
BB	0.04
MRA	0.04
Ivabradine	0.36
Diuretics	0.03
Statins	0.13
Angiotensin receptor-neprilysin inhibitors	0.54
Biomarkers cost	14.00
NT-proBNP (pg/mL)	12.00
hs T-Troponin (ng/mL)	2.00

ACEI angiotensin-converting enzyme inhibitor, ARA aldosterone receptor antagonist, BB betablockers, MRA mineralocorticoid receptor antagonist, NYHA New York Heart Association, NT-proBNP N-terminal pro-brain natriuretic peptide

ISSN: 1477-7525